These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 16912434)

  • 1. Transfusion transmitted leishmaniasis: a case report and review of literature.
    Dey A; Singh S
    Indian J Med Microbiol; 2006 Jul; 24(3):165-70. PubMed ID: 16912434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The first probable case of platelet transfusion-transmitted visceral leishmaniasis.
    Mathur P; Samantaray JC
    Transfus Med; 2004 Aug; 14(4):319-21. PubMed ID: 15285729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital transmission of visceral leishmaniasis (Kala Azar) from an asymptomatic mother to her child.
    Meinecke CK; Schottelius J; Oskam L; Fleischer B
    Pediatrics; 1999 Nov; 104(5):e65. PubMed ID: 10545591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular characterization of clinical isolates from Indian Kala-azar patients by MLEE and RAPD-PCR.
    Manna M; Majumder HK; Sundar S; Bhaduri AN
    Med Sci Monit; 2005 Jul; 11(7):BR220-7. PubMed ID: 15990683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of visceral leishmaniasis in India.
    Bora D
    Natl Med J India; 1999; 12(2):62-8. PubMed ID: 10416321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani.
    Lira R; Sundar S; Makharia A; Kenney R; Gam A; Saraiva E; Sacks D
    J Infect Dis; 1999 Aug; 180(2):564-7. PubMed ID: 10395884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Imported visceral leishmaniasis (kala azar) in a German infant].
    Emeis M; Liesenfeld O; Henze G; Meredith S; Schoone G; Stück B
    Klin Padiatr; 1995; 207(6):347-9. PubMed ID: 8569138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on stibanate resistant Leishmania donovani isolates of Indian origin.
    Pal S; Mandal A; Duttagupta S
    Indian J Exp Biol; 2001 Mar; 39(3):249-54. PubMed ID: 11495284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A search for Leishmania in normal skin and blood of Kala-Azar patients from Bihar, India.
    Saran R; Gupta AK; Prasad LS
    J Commun Dis; 1988 Mar; 20(1):89-90. PubMed ID: 3230291
    [No Abstract]   [Full Text] [Related]  

  • 10. Seroepidemiological study on kala-azar in Baringo District, Kenya.
    Jahn A; Lelmett JM; Diesfeld HJ
    J Trop Med Hyg; 1986 Apr; 89(2):91-104. PubMed ID: 3021967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis.
    Singh R; Kumar D; Ramesh V; Negi NS; Singh S; Salotra P
    J Infect Dis; 2006 Aug; 194(3):302-6. PubMed ID: 16826477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Visceral leishmaniasis. Personal observation and review of epidemiology, clinical aspects and therapy].
    Dickerhoff R; Müller A; Bode U
    Klin Padiatr; 1990; 202(5):347-51. PubMed ID: 2170739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vectorial efficacy of Phlebotomus argentipes in Kala-azar endemic foci of Bihar (India) under natural and artificial conditions.
    Kumar V; Kishore K; Palit A; Keshari S; Sharma MC; Das VN; Shivakumar S; Roy MS; Sinha NK; Prasad M; Kar SK
    J Commun Dis; 2001 Jun; 33(2):102-9. PubMed ID: 12170928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Phlebotomus alexandri Sinton, 1928 in the transmission of kala-azar.
    Guan LR; Xu YX; Li BS; Dong J
    Bull World Health Organ; 1986; 64(1):107-12. PubMed ID: 3488133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kala-Azar at high altitude.
    Mahajan SK; Machhan P; Kanga A; Thakur S; Sharma A; Prasher BS; Pal LS
    J Commun Dis; 2004 Jun; 36(2):117-20. PubMed ID: 16295673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic heterogeneity among visceral and post-Kala-Azar dermal leishmaniasis strains from eastern India.
    Dey A; Singh S
    Infect Genet Evol; 2007 Mar; 7(2):219-22. PubMed ID: 17027344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hunt for an elusive source of pyrexia in a foreign worker.
    Lew JW; Koh CK; Selvan VS; Shen E
    Singapore Med J; 2007 Apr; 48(4):e111-3. PubMed ID: 17384865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mechanism of drug resistance in kala azar field isolates.
    Singh N; Singh RT; Sundar S
    J Infect Dis; 2003 Aug; 188(4):600-7. PubMed ID: 12898450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kala-azar in Uttar Pradesh--a study of 66 patients.
    Mittal V; Singh VK; Ichhpujani RL
    J Commun Dis; 2002 Mar; 34(1):43-9. PubMed ID: 12718341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Kala-azar acquired in Croatia].
    Wenzl H; Petritsch W; Decrinis M; Schreiber F; Warnkross H; Pristautz H; Krejs GJ
    Wien Klin Wochenschr; 1992; 104(24):757-60. PubMed ID: 1337639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.